calaspargase pegol: Clinical Trials

25 trials of calaspargase pegol, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

10 recruiting, 8 active not recruiting, 3 completed, 2 not yet recruiting. 15 Phase 2, 7 Phase 3, 5 Phase 1, 1 Early Phase 1, 1 Not applicable.

By phase and status

PhaseTrialsStatus
Phase 215Recruiting 6, Active not recruiting 5, Not yet recruiting 2, Terminated 1, Withdrawn 1
Phase 37Active not recruiting 3, Completed 1, Not yet recruiting 1, Recruiting 1, Terminated 1
Phase 15Active not recruiting 2, Recruiting 2, Completed 1
Early Phase 11Recruiting 1
Not applicable1Completed 1

Follow calaspargase pegol: new trials by email Literature Review of calaspargase pegol trials Research Report on calaspargase pegol

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Testing Blinatumomab With or Without Revumenib in Patients With B-cell Acute Lymphoblastic Leukemia With a Genetic Change Requiring More Treatment
Biospecimen Collection, Blinatumomab, Bone Marrow Aspiration - Acute Leukemia of Ambiguous Lineage, B Acute Lymphoblastic Leukemia
Phase 2Not yet recruitingSWOG Cancer Research Network902026-10-142026-10-13
Testing the Addition of Daratumumab to Chemotherapy for Treating Patients With Newly-Diagnosed T-Cell Lymphoblastic Leukemia (T-ALL) and T-Cell Lymphoblastic Lymphoma (T-LL)
Biopsy Procedure, Biospecimen Collection, Bone Marrow Aspiration - Stage II T Lymphoblastic Leukemia/Lymphoma, Stage III T Lymphoblastic Leukemia/Lymphoma
Phase 2 / Phase 3Not yet recruitingChildren's Oncology Group17082026-08-282026-07-30
A Phase 2 Study to Evaluate Efficacy of Calaspargase Pegol-mknl and Decitabine Combined With Venetoclax in Pediatric, Adolescent, and Young Adult Patients With Relapsed/Refractory T-cell Acute Lymphoblastic Leukemia (T-ALL) and T- Cell Lymphoblastic Lymphoma (T-LLy)
Decitabine, Venetoclax, Calaspargase pegol-mknl - T-cell Acute Lymphoblastic Leukemia, T-Cell Lymphoblastic Lymphoma
Phase 2RecruitingM.D. Anderson Cancer Center222025-09-252026-09-18
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
Asparaginase Erwinia chrysanthemi, Biospecimen Collection, Blinatumomab - Acute Leukemia of Ambiguous Lineage, B Acute Lymphoblastic Leukemia
Phase 2RecruitingNational Cancer Institute (NCI)1532025-06-052026-10-27
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
Biospecimen Collection, Blinatumomab, Bone Marrow Biopsy - B Acute Lymphoblastic Leukemia
Phase 2RecruitingNational Cancer Institute (NCI)2222025-05-302026-10-27
Therapy for Newly Diagnosed Patients With B-Cell Precursor Acute Lymphoblastic Leukemia and Lymphoma
Dexamethasone, Vincristine, Inotuzumab - Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma
Phase 2RecruitingSt. Jude Children's Research Hospital1282025-01-232026-07-16
Adding Dasatinib Or Venetoclax To Improve Responses In Children With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (ALL) Or Lymphoma (T-LLY) Or Mixed Phenotype Acute Leukemia (MPAL)
Dexamethasone, Vincristine, Daunorubicin - T-cell Acute Lymphoblastic Leukemia, T-cell Lymphoma
Phase 2RecruitingSt. Jude Children's Research Hospital1002024-12-272026-08-10
Adding Targeted Drugs to Usual Chemotherapy for Adults With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (T-ALL) and T-Cell Lymphoblastic Lymphoma (T-LBL)
Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy - T Acute Lymphoblastic Leukemia, T Lymphoblastic Lymphoma
Phase 2WithdrawnNational Cancer Institute (NCI)2024-08-092024-05-17
A Study of Revumenib in Combination With Chemotherapy for Patients Diagnosed With Relapsed or Refractory Leukemia
Biospecimen Collection, Bone Marrow Aspiration, Calaspargase Pegol - Recurrent Acute Leukemia of Ambiguous Lineage, Recurrent Acute Lymphoblastic Leukemia
Phase 2Active not recruitingChildren's Oncology Group782024-01-082026-08-25
Studying the Effect of Levocarnitine in Protecting the Liver From Chemotherapy for Leukemia or Lymphoma
Biospecimen Collection, Calaspargase Pegol, Levocarnitine - B Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1
Phase 3Active not recruitingChildren's Oncology Group4402023-08-242026-08-21
CalPeg for Newly Diagnosed Acute Lymphoblastic Leukemia (ALL)
Hyper CVAD Protocol (Standard of Care Multi-Agent Chemotherapy), Calaspargase Pegol, Rituximab - Acute Lymphoblastic Leukemia
Phase 1RecruitingH. Lee Moffitt Cancer Center and Research Institute72023-05-012026-03-06
Venetoclax Basket Trial for High Risk Hematologic Malignancies
Venetoclax, Azacitidine, Cytarabine - Myelodysplastic Syndromes, de Novo, Myelodysplastic Syndromes, Secondary
Phase 1RecruitingAndrew E. Place, MD302023-03-292026-03-12
Trial Treating Relapsed Acute Lymphoblastic Leukemia With Venetoclax and Navitoclax
Venetoclax, Navitoclax, Dexamethasone - Refractory Acute Lymphoblastic Leukemia, Relapsed Acute Lymphoblastic Leukemia
Phase 1 / Phase 2Active not recruitingSt. Jude Children's Research Hospital352022-08-252026-10-15
Calaspargase Pegol-Mnkl and Cobimetinib for the Treatment of Locally Advanced or Metastatic Pancreatic Cancer
Biopsy, Calaspargase Pegol-mknl, Cobimetinib - Locally Advanced Pancreatic Adenocarcinoma, Metastatic Pancreatic Adenocarcinoma
Phase 1CompletedOHSU Knight Cancer Institute152022-08-092026-07-23
Phase 1 of Calaspargase Pegol-mknl W/ Cytarabine and Idarubicin in Newly Diagnosed AML
Calaspargase pegol-mknl - Acute Myeloid Leukemia
Phase 1Active not recruitingWest Virginia University62021-09-272026-09-02
SPARK-ALL: Calaspargase Pegol in Adults With ALL
Calaspargase pegol (S95015) - Acute Lymphoblastic Leukemia
Phase 2 / Phase 3TerminatedInstitut de Recherches Internationales Servier422021-07-072026-10-29
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
3-Dimensional Conformal Radiation Therapy, Asparaginase Erwinia chrysanthemi, Biospecimen Collection - Down Syndrome, Recurrent B Acute Lymphoblastic Leukemia
Phase 2RecruitingNational Cancer Institute (NCI)4612020-12-172026-11-12
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
Biospecimen Collection, Blinatumomab, Bone Marrow Aspiration - B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma
Phase 3RecruitingChildren's Oncology Group59512019-10-312026-08-25
Chemoimmunotherapy and Allogeneic Stem Cell Transplant for NK T-cell Leukemia/Lymphoma
Methotrexate, pralatraxate,, Ifosfamide - NK-Cell Lymphoma, NK-Cell Leukemia
Early Phase 1RecruitingNew York Medical College402019-03-012026-08-18
Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
Allogeneic Hematopoietic Stem Cell Transplantation, Calaspargase Pegol, Cyclophosphamide - Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia
Phase 3Active not recruitingChildren's Oncology Group3522017-08-082026-10-05

Showing 20 of 25. Sign in to see all of them.

Conditions studied

Precursor Cell Lymphoblastic Leukemia-Lymphoma (11)  ·  Burkitt Lymphoma (9)  ·  Leukemia, Biphenotypic, Acute (8)  ·  Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (8)  ·  Leukemia (2)  ·  Lymphoma (2)  ·  Precursor B-Cell Lymphoblastic Leukemia-Lymphoma (2)  ·  Down Syndrome (1)  ·  Leukemia, Large Granular Lymphocytic (1)  ·  Leukemia, Myeloid, Acute (1)  ·  Lymphoma, T-Cell (1)  ·  Lymphoma, T-Cell, Peripheral (1)  ·  Myelodysplastic Syndromes (1)  ·  Neoplasm Metastasis (1)  ·  Pancreatic Neoplasms (1)

Sponsors

Children's Oncology Group (8)  ·  National Cancer Institute (NCI) (4)  ·  St. Jude Children's Research Hospital (4)  ·  Andrew E. Place, MD (1)  ·  Dana-Farber Cancer Institute (1)  ·  H. Lee Moffitt Cancer Center and Research Institute (1)  ·  Institut de Recherches Internationales Servier (1)  ·  M.D. Anderson Cancer Center (1)  ·  New York Medical College (1)  ·  OHSU Knight Cancer Institute (1)  ·  SWOG Cancer Research Network (1)  ·  West Virginia University (1)

Countries

United States (21)  ·  Canada (7)  ·  Puerto Rico (6)  ·  Australia (5)  ·  New Zealand (2)  ·  Austria (1)  ·  Belgium (1)  ·  Chile (1)  ·  Czechia (1)  ·  Finland (1)  ·  France (1)  ·  Germany (1)  ·  Hong Kong (1)  ·  Israel (1)  ·  Italy (1)

Top investigators

Andrea Biondi (1)  ·  Andrew E Place, MD, PhD (1)  ·  Andrew Place, MD (1)  ·  Anne L Angiolillo (1)  ·  Ashkan Emadi, MD, PhD (1)  ·  Bijal Shah, MD (1)  ·  Charles D Lopez (1)  ·  Dale J. Pullen, MD (1)  ·  Daniel J. DeAngelo, MD, PhD (1)  ·  David McCall, MD (1)  ·  Erin H Breese (1)  ·  Etan Orgel (1)  ·  Hiroto Inaba, MD, PhD (1)  ·  Ibrahim Aldoss (1)  ·  Jennifer L McNeer (1)

Results publications

PMID 41671463, PMID 35622074, PMID 30626253, PMID 33026184, PMID 34228505, PMID 35007127, PMID 36625831, PMID 38446568, PMID 41074700, PMID 41619724, PMID 42154791

NIH funding

U10CA180886 (8), U10CA180888 (2), 2017 (1), U10CA030969 (1), U10CA098543 (1), U24CA196173 (1), UG1CA189955 (1)